Literature DB >> 12694381

Biochemical and molecular studies using human autopsy brain tissue.

Matthew R Hynd1, Joanne M Lewohl, Heather L Scott, Peter R Dodd.   

Abstract

The use of human brain tissue obtained at autopsy for neurochemical, pharmacological and physiological analyses is reviewed. RNA and protein samples have been found suitable for expression profiling by techniques that include RT-PCR, cDNA microarrays, western blotting, immunohistochemistry and proteomics. The rapid development of molecular biological techniques has increased the impetus for this work to be applied to studies of brain disease. It has been shown that most nucleic acids and proteins are reasonably stable post-mortem. However, their abundance and integrity can exhibit marked intra- and intercase variability, making comparisons between case-groups difficult. Variability can reveal important functional and biochemical information. The correct interpretation of neurochemical data must take into account such factors as age, gender, ethnicity, medicative history, immediate ante-mortem status, agonal state and post-mortem and post-autopsy intervals. Here we consider issues associated with the sampling of DNA, RNA and proteins using human autopsy brain tissue in relation to various ante- and post-mortem factors. We conclude that valid and practical measures of a variety of parameters may be made in human brain tissue, provided that specific factors are controlled.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694381     DOI: 10.1046/j.1471-4159.2003.01747.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  64 in total

Review 1.  Proteomics for protein expression profiling in neuroscience.

Authors:  Willard M Freeman; Scott E Hemby
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  The apoptotic thanatotranscriptome associated with the liver of cadavers.

Authors:  Gulnaz T Javan; Ismail Can; Sheree J Finley; Shivani Soni
Journal:  Forensic Sci Med Pathol       Date:  2015-08-30       Impact factor: 2.007

Review 3.  Beyond genome-wide significance: integrative approaches to the interpretation and extension of GWAS findings for alcohol use disorder.

Authors:  Jessica E Salvatore; Shizhong Han; Sean P Farris; Kristin M Mignogna; Michael F Miles; Arpana Agrawal
Journal:  Addict Biol       Date:  2018-01-09       Impact factor: 4.280

4.  Continuous monitoring of post mortem temperature changes in the human brain.

Authors:  B Gulyás; J Dobai; G Szilágyi; G Csécsei; G Székely
Journal:  Neurochem Res       Date:  2006-03-29       Impact factor: 3.996

Review 5.  Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity.

Authors:  F Tribl; K Marcus; G Bringmann; H E Meyer; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

Review 6.  Autopsy Biobanking: Biospecimen Procurement, Integrity, Storage, and Utilization.

Authors:  Randy S Tashjian; Ryan R Williams; Harry V Vinters; William H Yong
Journal:  Methods Mol Biol       Date:  2019

7.  RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays.

Authors:  Antje Koppelkamm; Benedikt Vennemann; Sabine Lutz-Bonengel; Tony Fracasso; Marielle Vennemann
Journal:  Int J Legal Med       Date:  2011-05-17       Impact factor: 2.686

8.  Transcriptional correlates of human substance use.

Authors:  Elin Lehrmann; William J Freed
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  A quantitative meta-analysis of brain glutamate metabolites in aging.

Authors:  David R Roalf; Valerie J Sydnor; Madison Woods; David A Wolk; J Cobb Scott; Ravinder Reddy; Paul J Moberg
Journal:  Neurobiol Aging       Date:  2020-07-21       Impact factor: 4.673

Review 10.  Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?

Authors:  Guillermo Moya-Alvarado; Noga Gershoni-Emek; Eran Perlson; Francisca C Bronfman
Journal:  Mol Cell Proteomics       Date:  2015-12-11       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.